Wulf Fischer-Knuppertz

Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ.

H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany.

Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany.

HEAD Sport GmbH engages in the development, manufacture, and sale of sporting goods, sporting articles, as well as sports and leisure wear. It also markets and distributes ski bindings. The company was founded on June 25, 2009 and is headquartered in Kennelbach, Austria.

MIG Verwaltungs AG is a private equity investment firm headquartered in Munich, Germany. It was founded in 2004 by entrepreneurs and financial institutions, to follow up on the success of the venture capital investment vehicles Global Chance Fund and Global Asset Fund, with which MIG's management had been involved.

AMSilk GmbH engages in the production of fiber and biopolymers.It offers implant coating, medical devices for OTC wound care, functional cosmetics, cell biology device kits, biosteel spidersilk fibers and spidersilk research license. It serves the biosteel fibers, medical devices, and cosmetic ingredients industry. The firm's materials are to be applied in numerous fields to improve existing products or to develop materials for completely new applications, which could not be realized until now due to the lack of an appropriate material. The company was founded by Axel H. Leimer, Thomas Scheibel, and Lin Römer in 2008 and is headquartered in Planegg, Germany.

Metabolomic Discoveries GmbH provides research and analytical services focusing on global metabolite profiling and fingerprinting. The firm uses technologies such as gas chromatography-mass spectrometry systems, Quadrupole time-of-flight mass spectrometers coupled to an ultra performance liquid chromatograph, Triple-Quadrupole mass spectrometer with ultrafast technology to analyze known and unknown metabolites in a sample. Its services include metabolite profiling, study of the lipidome, central metabolism quantification profiling, flavor profiling, measurement of non-organic or mineral elements in a biological sample, and flux analysis. The company was founded by Sandra Trenkamp and Nicolas Schauer in 2009 and is headquartered in Potsdam-Golm, Germany.

cynora GmbH engages in the research and development services in the field of homogenous catalysis. It offers Organic Light-Emitting Diodes and Thermally Activated Delayed Fluorescence. The company was founded by Thomas Baumann, Stefan Dahmen, Stefan Brase, Michael Bachle, and Marcus Lehnen in 2003 and is headquartered in Bruchsal, Germany.

PIA Performance Interactive Alliance GmbH provides digital marketing services. It specializes in digital strategy, marketing automation, and digital performance marketing for content and campaign management. The company was founded on July 25, 2013 and is headquartered in Hamburg, Germany.

Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX.

apceth Biopharma GmbH operates as a contract development & manufacturing organization. The firm specializes in cell-based and gene therapy products (Advanced Therapy Medicinal Products, ATMPs). Its GMP services include quality management, quality control, assay development, process development, cell banking & formulation and project management. The company was founded in 2007 and is headquartered in Munich, Germany.

iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany.